MetLife (MET) Director William E. Kennard Receives 294-Share Award

What Happened William E. Kennard, a director of MetLife, received 294 shares as an award/acquisition (Form 4 code A) on 2026-09-08. The shares were reported at $95.50 each for a total value of $28,077. The filing (accession 0001198236-26-000013) was submitted on 2026-09-10. According to the filing footnote, this acquisition reflects imputed reinvestment of dividends on deferred shares under MetLife’s Deferred Compensation Plan for Non-Management Directors (see F1) rather than an open-market purchase.

Key Details

• Transaction date: 2026-09-08; Form 4 filed: 2026-09-10 (within the typical 2-business-day reporting window).
• Type: Grant/Award/Acquisition (code A).
• Amount: 294 shares at $95.50 per share; aggregate value $28,077.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnotes: F1 — imputed reinvestment of dividends on deferred shares under the Deferred Compensation Plan for Non-Management Directors. F2 — references shares held in trust under the MetLife Policyholder Trust.
• No 10b5‑1 plan, cashless exercise, or tax-withholding sale is indicated for this transaction in the provided details.

Context This was a dividend-reinvestment style award of deferred shares—a common, administrative form of acquiring additional company stock for non-management directors. It reflects reinvested dividends and deferred compensation mechanics rather than a discretionary cash purchase or sale by the director, so it should be viewed as routine reporting of compensation/deferral activity rather than a direct trading signal.